Latest Press Releases
View all
TimeHeadline
24m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
56m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
56m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
56m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
56m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Mineralys Therapeutics, Inc. Common Stock logo

Mineralys Therapeutics, Inc. Common Stock

About

Mineralys Therapeutics, Inc. Common Stock (NASDAQ:MLYS) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 24 2026
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
Mar 12 2026
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Mar 9 2026
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
Mar 9 2026
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026
Feb 12 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Financials

Revenue
$0
Market Cap
$2.33 B
EPS
-2.29

Community Chat

Ask AI

6ix6ix